These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 18984941

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats.
    Cettour-Rose P, Rohner-Jeanrenaud F.
    Endocrinology; 2002 Jun; 143(6):2277-83. PubMed ID: 12021192
    [Abstract] [Full Text] [Related]

  • 23. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia.
    Bonifazi A, Ellenberger M, Farino ZJ, Aslanoglou D, Rais R, Pereira S, Mantilla-Rivas JO, Boateng CA, Eshleman AJ, Janowsky A, Hahn MK, Schwartz GJ, Slusher BS, Newman AH, Freyberg Z.
    Diabetes; 2024 Sep 01; 73(9):1411-1425. PubMed ID: 38869519
    [Abstract] [Full Text] [Related]

  • 24. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA.
    Psychopharmacology (Berl); 2003 Apr 01; 167(1):103-11. PubMed ID: 12632249
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
    Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.
    Metabolism; 2008 Nov 01; 57(11):1597-607. PubMed ID: 18940400
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.
    Metabolism; 2013 Nov 01; 62(11):1641-50. PubMed ID: 23932644
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Regional fat pad growth and cellularity in obese zucker rats: modulation by caloric restriction.
    Hausman DB, Fine JB, Tagra K, Fleming SS, Martin RJ, DiGirolamo M.
    Obes Res; 2003 May 01; 11(5):674-82. PubMed ID: 12740458
    [Abstract] [Full Text] [Related]

  • 37. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to a systemic supply of calories from glucose.
    Gilbert M, Magnan C, Turban S, André J, Guerre-Millo M.
    Diabetes; 2003 Feb 01; 52(2):277-82. PubMed ID: 12540597
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.
    Holubová M, Zemenová J, Mikulášková B, Panajotova V, Stöhr J, Haluzík M, Kuneš J, Železná B, Maletínská L.
    J Endocrinol; 2016 May 01; 229(2):85-96. PubMed ID: 26906745
    [Abstract] [Full Text] [Related]

  • 40. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity.
    van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J.
    Obesity (Silver Spring); 2012 Aug 01; 20(8):1738-40. PubMed ID: 22307070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.